Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655057 · ClinicalTrials.gov registry record · Phase 2
Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT00655057: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00655057 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00655057, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
This study will examine changes in brain dopamine transporter activity before and after antidepressant therapy.
Interventions
- BEHAVIORAL Cognitive behavioral therapy (CBT)
- DRUG S-citalopram
- PROCEDURE TRODAT-1 single photon emission computed tomographic (SPECT) imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2005-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655057
The ClinicalTrials.gov registry entry for NCT00655057 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive behavioral therapy (CBT) is the first listed.
NCT00655057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655057 about?
NCT00655057 is a clinical study titled "Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression". This study will examine changes in brain dopamine transporter activity before and after antidepressant therapy.
What is the current status of trial NCT00655057?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2005-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00655057?
The interventions under investigation include: Cognitive behavioral therapy (CBT) (BEHAVIORAL), S-citalopram (DRUG), TRODAT-1 single photon emission computed tomographic (SPECT) imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00655057?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.